Albireo Pharma, Inc. ALBO
44.15 +44.15
Day range unavailable
52-week range unavailable
News
businesswire.com Albireo Energy Announces CEO Succession as Company Enters Next Stage of Accelerated Expansion EDISON, N.J.--(BUSINESS WIRE)--Albireo Energy, a leading independent building controls and energy services provider and a Huron Capital portfolio company, today announced that Kevin Baxter has been…
businesswire.com Albireo Energy Earns Great Place To Work Certification™ for Eighth Consecutive Year EDISON, N.J.--(BUSINESS WIRE)--Albireo Energy, a leading independent building controls and energy services provider and Huron Capital portfolio company, has been Certified™ by Great Place To Work®…
businesswire.com Albireo Energy Names Mergers and Acquisitions Executive EDISON, N.J.--(BUSINESS WIRE)--Albireo Energy, a leading independent building controls and energy services provider and a Huron Capital portfolio company, today announced the appointment of Brad…
businesswire.com Albireo Energy Strengthens Presence in Arizona with Local Leadership and Proven Expertise PHOENIX--(BUSINESS WIRE)--Albireo Energy, a leading independent provider of building automation and energy services, today announced the continued growth of its Arizona Division and the appointment…
businesswire.com Albireo Energy Launches Private Cloud Services to Enhance Building System Data Security and Performance EDISON, N.J.--(BUSINESS WIRE)--Albireo Energy, a leading independent building controls and energy services provider and a Huron Capital portfolio company, today announced the launch of Private Cloud…
businesswire.com Albireo Launches Critical Alarm Management Service for Mission Critical Buildings that Require Uptime and Reliability EDISON, N.J.--(BUSINESS WIRE)-- #BAS--Albireo Energy, a leading independent building controls and energy services provider, and Huron Capital portfolio company, today announced the launch of Critical…
businesswire.com Albireo Energy Sees Buildings in a Different Way as it Unveils New Brand Identity EDISON, N.J.--(BUSINESS WIRE)-- #BuildingSystemsPerformance--Albireo Energy, a leading independent building controls and energy services provider and Huron Capital portfolio company, revealed its new…
zacks.com Is Albireo Pharma (ALBO) Stock Outpacing Its Medical Peers This Year? Here is how Albireo Pharma (ALBO) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.
prnewswire.com SHAREHOLDER ALERT: Weiss Law Reminds AQUA, LPTX, CNCE, and ALBO Shareholders About Its Ongoing Investigations NEW YORK , Jan. 30, 2023 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your…
seekingalpha.com Albireo Pharma: Elucidating The Ipsen Buyout (Rating Upgrade) Albireo Pharma, Inc. has entered into an agreement to get acquired by Ipsen. Bylvay is already approved for PFIC. Nevertheless, the stellar drug is poised to gain additional labels for Alagille…
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023 
benzinga.com Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
fool.com 2 Tiny Nasdaq Stocks Making Major Merger Moves Monday The market is moving higher, and these small companies are helping.
benzinga.com Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday Gainers
benzinga.com Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session Gainers
seekingalpha.com Albireo Pharma, Inc. (ALBO) Q3 2022 Earnings Call Transcript Albireo Pharma, Inc. (NASDAQ:ALBO ) Q3 2022 Results Conference Call November 8, 2022 4:30 PM ET Company Participants Hans Vitzthum - Managing Director, LifeSci Advisors Ron Cooper - President and…
zacks.com Albireo Pharma (ALBO) Reports Q3 Loss, Tops Revenue Estimates Albireo Pharma (ALBO) delivered earnings and revenue surprises of -1.61% and 1.58%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?- benzinga.com Earnings Scheduled For November 8, 2022 Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
globenewswire.com Albireo to Present Late Breaking Bylvay® (odevixibat) Data at AASLD 2022 – Oral late breaker with new results from positive Phase 3 ASSERT study in Alagille syndrome (ALGS)
globenewswire.com Albireo to Report Q3 2022 Financial Results on November 8, 2022 Conference call and webcast to be held at 4:30 pm ET Conference call and webcast to be held at 4:30 pm ET
seekingalpha.com Albireo: Strong Phase 3 Data Foretells More Upside Sales for Bylvay's first approved indication is increasing. The company recently posted superb data for an orphan disease known as Alagille Syndrome.
zacks.com Albireo (ALBO) Up on Results From Alagille Syndrome Study Albireo Pharma (ALBO) reports positive top-line data from a late-stage study evaluating Bylvay in Alagille syndrome. The study meets the primary and key secondary endpoint Stock up.- benzinga.com Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.
marketwatch.com Albireo's stock is up 10% on plans to seek FDA approval for drug for rare disorder Shares of Albireo Pharma Inc. ALBO, +6.86% gained 10.4% in premarket trading on Tuesday after the company said it is seeking Food and Drug Administration approval to use its medication Bylvay as a…
seekingalpha.com Albireo Pharma: Assessing The Sagard Deal Albireo Pharma, Inc. is expanding its Bylvay label for two other rare liver conditions, biliary atresia and Alagille syndrome. The company is poised to report topline data for the Phase 3 (ASSERT)…
zacks.com Albireo Pharma (ALBO) Stock Jumps 11%: Will It Continue to Soar? Albireo Pharma (ALBO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near…
benzinga.com Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to…- benzinga.com Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 297 companies achieved new lows for the year.- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 529 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 109 stocks hit new 52-week lows.
benzinga.com This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.- benzinga.com Why GreenBox POS Is Trading Higher By Around 72%, Here Are 70 Stocks Moving In Tuesday's Mid-Day Session Gainers GreenBox POS (NASDAQ: GBOX) shares jumped 72.4% to $2.19 as the company reported better-than-expected Q2 sales.
- benzinga.com Earnings Scheduled For August 15, 2022 Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's trading, 1214 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 94 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 215 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For May 16, 2022 Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
- benzinga.com 80 Biggest Movers From Yesterday Gainers
- benzinga.com Earnings Scheduled For March 1, 2022 Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter.
- benzinga.com Earnings Scheduled For November 4, 2021 Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
- benzinga.com Earnings Scheduled For August 5, 2021 Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
- benzinga.com Earnings Scheduled For May 6, 2021 Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.
- benzinga.com Earnings Scheduled For February 25, 2021 Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings at $0.23 per share on revenue of $4.78 billion.
- benzinga.com Stocks That Hit 52-Week Lows On Monday
- benzinga.com Stocks That Hit 52-Week Lows On Thursday
benzinga.com 52 Biggest Movers From Wednesday 
benzinga.com Stocks That Hit 52-Week Lows On Monday - benzinga.com Stocks That Hit 52-Week Lows On Wednesday
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday